Vektor’s technology provides clinical management of arrhythmias by providing physicians with actionable information using the non-invasive “vMap™” technology.Visit site
Funded in July 2015 and led by David Krummen and Andrew McCulloch
Formation of new startup, Vektor Medical in 2017
Successfully closes convertible note funding round in 2018
vMap™ protype created and, under IRB, successful first patient research use in 2018
Successful use of vMap technology in conjunction with Radioablation Therapy presented at American Heart Association in November 2019
Closes series seed financing round fully subscribed in 2019
Benefits of Vektor Medicals vMap presented at American Heart Association and FDA clinical study begins in December, 2020
5-year NIH renewal application of the Cardiac Atlas Project that was recently funded for $3,134,249
This is one of many successful projects with GEM UCSD.
Contact us to find out about our other projects.